MS Active Source

Treatment

• Introduction
• Introduction to MS
• MS treatments
  • Intro to MS treatments
  • Interferons
  • Avonex
  • Betaferon
  • Rebif
  • Glatiramer acetate
  • Copaxone
  • Natalizumab
  • Tysabri
  • Treatment of relapses
  • Risk-sharing scheme
  • Progressive MS
• Positive approach
• Newly diagnosed?
• Relative with MS
• Links
• Principles of treatment

Progressive MS - Treatment Options

The underlying cause of the growing disability seen in more progressive MS is still uncertain. It probably results from long-term damage to the nerves themselves, rather than to the myelin sheath that wraps around them. Unfortunately most of the treatments currently available for MS concentrate on treating the inflammation that leads to demyelination. So, with the exception of Betaferon, they may not be suitable for people with more progressive MS.

Secondary Progressive Multiple Sclerosis 

Clinical studies that have investigated the use of beta interferon-1a/b drugs in secondary progressive MS have so far produced conflicting results. None of these agents are presently prescribed for people with secondary progressive MS unless they are still having some relapses. Betaferon is currently the only DMT that can be used in secondary progressive MS.

Primary Progressive Multiple Sclerosis

There is presently no treatment for people who have primary progressive MS. Studies investigating the pathogenic processes that underlie this form of the disease may help provide drugs in the future (refT13).

Quick Links

• Treatment rights
• Your questions
• Glossary
• Making the most of treatment
• Newly diagnosed

Supported by